2-(Allylthio)pyrazine suppresses the growth and proliferation of human promyelocytic leukemia (HL-60) cells via induction of apoptosis

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4073-4080

  Lee, Eunyong ^a   Kong, Gu ^b   Lee, Su Jeen ^b   Kim, Nak Doo ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

2 (Allylthio)pyrazine; Antiproliferation; Apoptosis; Human promyelocytic; Leukemia cells; Organosulfur compounds

Indexed keywords

2 (ALLYLTHIO)PYRAZINE; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PYRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; MICROSCOPY; NUCLEOSOME; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 0032764101     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Heber D: The stinking rose: organosulfur compounds and cancer. Am J Clin Nutr 66: 425-426, 1997.
2. Lea MA: Organosulfur compounds and cancer. Adv Exp Med Biol 401: 147-154, 1996.
3. Sparnines VL, Barany G and Wattenberg L: Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 9: 131-134, 1988.
4. Srivastava SK, Hu X, Xia H, Zaren HA, Chatterjee ML, Agarwal R and Singh SV: Mechanism of differential efficacy of garlic organosulfides in preventing benzo[a]pyrene-induced cancer in mice. Cancer Lett 118: 61-67, 1997.
5. Nestle M: Broccoli sprouts in cancer prevention. Nutr Rev 56: 127-130, 1998.
6. Surh Y-J, Lee RC, Park KK, Mayne ST, Liem A and Miller JA: Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis and tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis 16: 2467-2471, 1995.
7. t- and N-nitrosodiethylamine-induced liver preneoplastic foci in rats fed naturally occurring allyl sulfide. Nutr Cancer 25: 61-70, 1996.
8. Pereira MA: Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Anticancer Res 15: 1953-1956, 1995.
9. Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, Stephens LC, Price R, Gray K and Kelloff GJ: Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5: 355-360, 1996.
10. Wargovich MJ, Imada O and Stephens LC: Initiation and post-initiation chemopreventive effects of diallyl sulfide on esophageal carcinogenesis. Cancer Lett 64: 39-42, 1992.
11. Zhang Y, Kensler TW, Cho C-G, Posner GH and Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91: 3147-3150, 1994.
12. Harber D, Siess M-H, Canivenc-Lavier, MC, Le Bon A-M and Suschetet: Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes. J Toxicol Environ Hlth 44: 423-434, 1995.
13. Hu X, Benson PJ, Srivastava SK, Mack LM, Xia H, Gupta V, Zaren HA and Singh SV: Glutathione S-transferase of female A/J mouse liver and forestomach and their differential induction by anti-carcinogenic organosulfides from garlic. Arch Biochem Biophys 336: 199-214, 1996.
14. Singh SV, Pan SS, Srivastava SK, Xia H, Hu X, Zaren HA and Orchard JL: Differential inducion of NAD(P)H:quinone oxido-reductase by anti-carcinogenic organosulfides from garlic. Biochem Biophys Res Commun 244: 917-920, 1998.
15. Zhang Y, Talalay P, Cho C-G and Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89: 2399-2403, 1992.
16. Talalay P, Fahey JW, Holtzclaw WD, Prestera T and Zhang Y: Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82/83: 173-179, 1995.
17. Maheo, K, Morel F, Langouet S, Kramer H, Le Ferree E, Ketterer B and Guillouzo A: Inhibition of cytochrome P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 57: 3649-3652, 1997.
18. Brady JF, Ishizaki H, Fukuto JM, Lin MC, Fadel A, Gape JM and Yang CS: Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol 4: 642-647, 1994.
19. Dragnev KH, Nims RW and Lubet RA: A structurally atypical phenobarbital-type inducer. Biochem Pharmacol 50: 2099-2104, 1995.
20. Reicks MM and Crankshaw DL: Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds. Nutr Cancer 25: 241-248, 1996.
21. Barcelo S, Gardiner JM, Gescher A and Chipman JK: CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17: 277-282, 1996.
22. Helzlsouer KJ and Kensler TW: Cancer Chemoprotection by oltipraz: experimental and clinical considerations. Prev Med 22: 783-795, 1993.
23. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V and Reddy BS: Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res 55: 1464-1472, 1995.
24. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ and Bertagnolli MM: Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56: 2556-2560, 1996.
25. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 56: 710-714, 1996.
26. Fesus L, Szondy Z and Uray I: Probing the molecular program of apoptosis by cancer chemopreventive agents. J Cell Biochem Suppl. 22: 151-161, 1995.
27. Thompson HJ, Strange R and Schedin PJ: Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1: 597-602, 1942.
28. Welch C, Wuarin L and Sidell N: Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Lett 63: 211-219, 1992.
29. Musk SR, Stephenson P, Smith TK, Stening P, Fyfe D and Johnson IT: Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29. Nutr Cancer 24: 289-298, 1995.
30. Sigounas G, Hooker J, Anagnostou A and Steiner M: S-Allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr Cancer 27: 186-191, 1997.
31. Sundaram SG and Milner JA: Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 17: 669-673, 1996.
32. Sigounas G, Hooker JL, Li W, Anagnostou A and Steiner M: S-Allylmercaptocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines. Nutr Cancer, 28: 153-159, 1997.
33. Sakamoto K, Lawson LD and Milner JA: Allyl sulfide from garlic suppresses the in vitro proliferation of human A549 lung tumor cells. Nutr Cancer 29: 152-156, 1997.
34. Piazza GA, Rham ALK, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R and Ahnen DJ: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoplosis. Cancer Res 55: 3110-3116, 1995.
35. Piazza GA, Rham AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R and Ahnen D: Apoptosis primarily accounts for the growth inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57: 2452-2459, 1997.
36. Kim ND, Kwak MK and Kim SG: Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem Pharmacol 53: 261-269, 1997.
37. Kim ND, Kim SG and Kwak MK: Induction of rat hepatic glutathionc S-transferase by allyl sulfide, allyl mercaptan, allyl methyl sulfide and 2-(allylthio)pyrazine. The International Toxicologists (Abstract of the 7th International Congress of Toxicology, July 2-6, Seattle, WA, USA), abstract number, 69-P-8, 1995.
38. Surh Y-J, Kim SG, Park K-K, Sohn Y, Lee J-M, Kim N-D and Miller JA: Chemoprentive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis and tumorigenesis induced by vinyl carbamate or vinyl carbamate epoxide. Carcinogenesis 19: 1263-1267, 1998.
39. Bursch W, Oberhammer and Schulte-Hermann R: Cell death by apoptosis and its protective role against disease. Trends in Pharmacol Sci 13: 245-251, 1992.
40. Danheiser SL: Apoptosis modulation gains drug company interest as critical therapeutic strategy. Genet Eng News, 15 (1): 22-23, 1995.
41. Dixon SC, Soriano BJ, Lush RM, Borner MM and Figg WD: Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmacother 31: 76-82, 1997.
42. Kerr JFR, Winterford CM and Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer (Phila) 73: 2013-2026, 1994.
43. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992.
44. Tang DG and Porter AT: Target to apoptosis: a hopeful weapon for prostate cancer. Prostate 32: 284-293, 1997.
45. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G and Boothman DA: b-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res 55: 3706-3711, 1995.
46. Li CJ, Wang C and Pardee AB: Induction of apoptosis by b-lapachone in human prostate cancer cells. Cancer Res 55: 3712-3715, 1995.
47. Agarwal N and Mehta K: Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Biochem Biophys Res Commun 230: 251-253, 1997.
48. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
49. Maldonado V, Melendez-Zajgla J and Ortega A: Modulation of NF-kB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res 381: 67-75, 1997.
50. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T and Bredesent DE: Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277, 1993.
51. Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG and Borner C: Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain. Biochem Biophys Res Commun 221: 340-345, 1996.
52. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH and Bredesen DE: The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 60: 1183-1186, 1993.
53. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH and Bredesen DE: Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90: 4533-4537, 1993.
54. Miyashita T, Krajewski S, Krajewska M, Wang HJ, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
55. Chiou S, Rao L and White E: Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14: 2556-2563, 1994.
56. Wolf D and Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790-794, 1985.
57. Yin X-M, Oltvai ZN and Lorsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369: 321-323, 1994.
58. Cooper JD, Michaelidis TM, Tzimagiorgis GZ, Sendtner M, Meyer M and Thoenen H: Cholinergic neuron-specific overexpression of Bax in ChAT Bax transgenic mice. So. Neurosci Abstr. 22: 570, 1996.
59. Kobayashi T, Ruan S, Clodi K, Kliche K-O, Shiku H, Andreeff M and Zhang W: Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 16: 1587-1591, 1998.
60. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
61. Fukamachi Y, Karasaki Y, Sugiura T, Itoh H, Abe T, Yamamura K and Higashi K: Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. Biochem Biophys Res Commun, 246: 364-369, 1998.
62. Zhivotovsky B, Burgess DH, Vanags DM and Orrenius S: Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Commun 230: 481-488, 1997.
63. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994.
64. Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.